Long COVID Atlas
Text Theme
Note

Some of what this page describes shows up only on specialized tests. A normal routine scan does not rule it out.

Mechanism

Endothelial dysfunction

Breathlessness when your chest scan reads clear. A heart that feels strained months after a mild infection. Both can trace back to the same place: the thin lining inside your blood vessels, called the endothelium. In long COVID that lining often stays damaged and inflamed long after the virus is gone, and because it sits in every vessel in the body, one fault surfaces in the lungs, the heart, and the clotting system at once.

New here and low on energy? Use the controls above to make the text bigger, switch to a softer color, or have this page read aloud. Read as little or as much as you like.

Start here: what the endothelium does

The endothelium is a single layer of cells lining every artery, vein, and capillary you have. Spread flat it would cover several tennis courts, yet it is only one cell thick. It is not passive plumbing. It decides, moment to moment, whether a vessel widens or narrows, whether blood clots or stays fluid, what crosses from blood into tissue, and whether inflammation switches on or off.

Healthy lining open · smooth · sealed Dysfunctional lining leak clot narrowed · leaky · clogged
The endothelium is the active lining of every vessel. Healthy, it keeps flow smooth and sealed. Dysfunctional, it narrows, leaks, and clogs.

When that lining is healthy you never notice it. When it is damaged, the failures are not subtle and they are not confined to one organ. The same injured endothelium that lets a lung capillary exchange oxygen poorly can also tip the blood toward clotting and stiffen the arteries feeding the heart. That is why a single mechanism can explain symptoms that look unrelated.

What damages it in long COVID

The clearest driver is the viral spike protein. Spike binds ACE2, the same receptor the virus uses to enter cells, and ACE2 sits in large amounts on endothelial cells. When spike occupies and depletes ACE2 it tips a balance: the protective, vessel-relaxing arm of the system falls while angiotensin II, which constricts vessels and drives inflammation, rises.3 Laboratory work shows spike on its own, with no live virus replicating, is enough to injure endothelial cells, push them into a senescent state, make them sticky to immune cells, and switch on tissue factor, the trigger that starts a clot.3,4

Healthy: ACE2 keeps the balance ACE2 converts angiotensin II into the protective, vessel-relaxing form endothelial cell surface ACE2 relaxAng IIbalanced Long COVID: spike occupies ACE2, the balance tips spike protein angiotensin II rises endothelial cell surface the balance tips spike blocks ACE2 → angiotensin II rises → vessels constrict & inflame → endothelial dysfunction
Spike protein docks onto ACE2, the same receptor the virus uses to enter cells. With ACE2 occupied and depleted, the protective arm that relaxes vessels falls and angiotensin II rises, tipping the balance toward constriction and inflammation. That tilt is endothelial dysfunction beginning.

This would matter little if it ended with the infection. The problem in long COVID is persistence. Fragments of spike and viral material have been detected in tissue and circulation for many months, which keeps the injury signal switched on rather than letting it settle.3

The immune response adds a second layer. People with long COVID show a measurably pro-thrombotic blood profile, with raised fibrinogen, thrombin, soluble endothelial protein C receptor, and C-reactive protein, all consistent with a lining that is inflamed and primed to clot rather than calm and anti-coagulant.5 Over time some endothelial cells age and shed into the bloodstream, and the count of these circulating endothelial cells tracks with persistent fatigue after COVID, which is part of why researchers read them as a signal of ongoing vascular damage.6

grademoderateauditwell-founded-mechanism

Why you can be breathless when the scan is normal

One of the most validating findings for patients comes from a specialized lung scan. Using hyperpolarized xenon gas, which a person breathes in during an MRI, researchers can watch oxygen-sized gas move from the air sacs, across the tissue barrier, and into red blood cells. In people with long COVID and ongoing breathlessness, that final transfer into red blood cells is reduced even when an ordinary CT scan and routine lung function tests read normal.2

Healthy air sac (oxygen in) vessel lining gas reaches red cells · ratio ~0.45 Long COVID air sac (oxygen in) vessel lining less reaches red cells · ratio ~0.31
A xenon-gas MRI watches oxygen cross from the air sacs into red blood cells. In long COVID that transfer drops even when an ordinary scan looks normal, because the bottleneck sits at the lining, not in the airways.

The numbers are concrete. In the Oxford studies the red-blood-cell-to-tissue-plasma ratio, a measure of how well gas crosses into the blood, fell to about 0.31 in post-COVID participants against roughly 0.45 in healthy volunteers, a significant gap despite structurally normal lungs.2 The bottleneck is not in the airways, it is at the interface between the air sacs and the smallest blood vessels, exactly where the endothelium lives. So when a clinician tells you your lungs look fine, both things can be true: the structure is intact and the exchange surface is still not working. The test-mismatch flag on this page marks that gap.

gradelow-moderateauditemergingnotenormal tests can miss this

The clotting link

A damaged lining and abnormal clotting are not two separate stories. When the endothelium is injured it exposes tissue factor and grips passing platelets, which helps explain the fibrinaloid microclots reported in long COVID, small clots that resist normal breakdown.4,5 The relationship runs in both directions: endothelial injury seeds clotting, and the resulting microclots">microclots">microclots and platelet activation injure the lining further. The microclots page lays out the contested parts of that evidence in full.

gradelow-moderateauditemerging

The heart risk, kept in proportion

The downstream cardiovascular signal is large in studies and worth understanding without alarm. In the largest analysis, a cohort of 153,760 US veterans who survived the first month after COVID, the risk of a new cardiovascular problem over the next year was raised across the board, with a hazard ratio of 1.63 for any cardiovascular outcome against uninfected controls.1 The excess came to about 45 additional cases per 1,000 people over the year. Specific risks ran from roughly 1.5 to 1.8 for heart-rhythm disturbances, around 2 to 3 for clots in veins and arteries, and up to 5.4 for inflammation of the heart muscle.1

Each dot is one person. Colored dots are the extra cardiovascular cases in a year.
The relative risk was 63 percent higher (hazard ratio 1.63), which sounds large. Held in proportion, the absolute increase is about 4 to 5 more people in 100 over a year (45 per 1,000). Both framings are true; keep them together.

Hold the relative and absolute numbers together. A hazard ratio of 1.63 means the risk was about 63 percent higher, which sounds dramatic, while an excess of roughly 45 per 1,000 means about 4 to 5 extra people in 100 across a full year. The risk climbed with how severe the acute infection was, and it was real even in people who were never hospitalized. That is a reason to take new chest symptoms seriously, not a reason to expect the worst.

grademoderateauditwell-founded-association

How it is measured

There is no single approved clinical test for endothelial dysfunction in long COVID. The markers researchers use, flow-mediated dilation (an ultrasound measure of how well an artery widens), counts of circulating endothelial cells, and blood markers such as von Willebrand factor and soluble endothelial protein C receptor, are mostly research tools today.6 They share a pattern with the xenon imaging: they can read abnormal when standard panels are normal. Useful to know if you are being told everything checks out while you still feel unwell. It does not yet translate into a test you can ask for at a routine visit.

grademoderateauditemergingnotetest-mismatch

What we don't know

Honest about the edges of the evidence. These are open questions, not settled answers.

  • Whether the damage is driven mainly by lingering virus, by the immune system, or by microclots, and how much each matters in any one person.
  • Whether any treatment aimed at the endothelium changes long-term symptoms, since none is proven yet.
  • Whether the research markers, flow-mediated dilation and circulating endothelial cells, can become reliable tests you could ask for at a routine visit.
  • How often the vessel-lining damage reverses on its own, and what predicts who recovers.
  • Why some people develop lasting vascular problems after a mild infection while others do not.
  • Whether the fibrinaloid microclot findings are reliably reproducible and clinically decisive, which is still contested.

What this means for you

If you have sat through appointments being told your tests look fine while your body plainly disagrees, this is the part to hold onto. What you are feeling has a physical basis in your blood vessels. It is not in your imagination, and it is not a failure of willpower or fitness.

No treatment is approved that repairs the endothelium directly in long COVID, so treat any clinic selling a vascular cure with caution. The raised cardiovascular risk in the first year is real but small for any one person, worth knowing and not worth living in fear of. Breathlessness with a clear scan is measurable, and you are allowed to say so and to ask whether the specialized tests that can see it are available to you. New or worsening chest pain, palpitations, or breathlessness deserve a proper look, and one normal test does not settle the question.

Rest is not giving up. Pacing is how a strained lining gets the chance to settle instead of being re-injured. The mechanisms upstream of this, the persistent spike protein, the viral reservoir, and the immune response, each have their own page, and the clotting link connects here from both sides. Whatever pace you read this at was the right one.

References

Every link opens the free full text, no paywall.

  1. Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583-590. PubMed Central, free full text ›
  2. Grist JT, Collier GJ, Walters H, et al. Lung abnormalities depicted with hyperpolarized xenon MRI in patients with Long COVID (the group’s earlier post-pneumonia study, Radiology 2021;301:E353, found the same pattern). Radiology. 2022;305(3):709-717. open access (White Rose), free full text ›
  3. Review. Cellular and molecular mechanisms of SARS-CoV-2 spike protein-induced endothelial dysfunction. Cells. 2026;15(3):234. PubMed Central, free full text ›
  4. Review. SARS-CoV-2 spike protein and Long COVID, part 1: impact of spike protein in pathophysiological mechanisms. Viruses. 2025;17(5):617. open access, free full text ›
  5. Research. Immune dysregulation and endothelial dysfunction associate with a pro-thrombotic profile in Long COVID. Front Immunol. 2025;16:1613195. open access, free full text ›
  6. Research. Virus-induced endothelial senescence as a cause and driving factor for ME/CFS and long COVID. Cell Death Dis. 2026. open access, free full text ›

Also named in the text: Smadja DM, et al. Circulating endothelial cells as a biomarker of persistent fatigue after COVID-19, Angiogenesis 2024;28:8; Thomas D, et al. CCL2-mediated endothelial injury drives cardiac dysfunction in long COVID, Nat Cardiovasc Res 2024;3:1249-1265.

Associated topics